ST
ABUS icon

Spot Trading’s Arbutus Biopharma ABUS Stock Holding History

Spot Trading’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-24,100
Closed -$509K – 3959
2014
Q3 		$509K Buy
+24,100
New +$394K ﹤0.01% 2547

Other funds holding ABUS

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SCM
Suffolk Capital Management New York $521M AUM 9.79% 1-Year Est. Return

Spot Trading's ABUS Position: Q2 2016 in Review

Spot Trading sold out of Arbutus Biopharma (ABUS) in Q2 2016, closing a stake of 1 share.

Spot Trading first reported a position in ABUS in Q3 2014 and held it in 2 quarters. The position peaked at $16K in Q3 2014. 51 funds tracked by Wall St. Rank hold ABUS as of Q2 2016.

  • Spot Trading reported no remaining Arbutus Biopharma position as of Q2 2016 after selling out during the quarter.
  • Spot Trading sold 1 Arbutus Biopharma share in Q2 2016.
  • Spot Trading first reported a position in Arbutus Biopharma in Q3 2014 and held it in 2 quarters.
  • Spot Trading's Arbutus Biopharma position peaked at $16K in Q3 2014.
  • 51 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q2 2016.

Based on Spot Trading's 13F filing for Q2 2016, filed 2 Aug 2016.